This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akpaka, P. E.
Right arrow Articles by Villegas, M. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akpaka, P. E.
Right arrow Articles by Villegas, M. V.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2009, p. 2670-2671, Vol. 47, No. 8
0095-1137/09/$08.00+0     doi:10.1128/JCM.00362-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

CASE REPORT

Emergence of KPC-Producing Pseudomonas aeruginosa in Trinidad and Tobago{triangledown}

Patrick E. Akpaka,1* William H. Swanston,1,2 Hyginus N. Ihemere,2 Adriana Correa,3 Julian A. Torres,3 Jose D. Tafur,3 Maria Camila Montealegre,3 John P. Quinn,4 and Maria Virginia Villegas3

The University of the West Indies, St. Augustine, Trinidad and Tobago,1 North Central Regional Health Authority, Champ Fleurs, Trinidad and Tobago,2 International Center for Medical Research and Training, Cali, Colombia,3 Pfizer Global Research and Development, New London, Connecticut4

Received 17 February 2009/ Returned for modification 10 April 2009/ Accepted 25 May 2009

In 2006, the first isolate of KPC-2-producing Pseudomonas aeruginosa in the world was identified in Colombia. Recently, similar strains have been reported in Puerto Rico. We now report KPC-2-producing P. aeruginosa in Trinidad and Tobago. Surveillance for similar strains is warranted, considering their wide geographic spread and known association with mobile genetic elements.

* Corresponding author. Mailing address: Room 26, Block 5, Pathology/Microbiology Unit, Eric Williams Medical Sciences Complex, Dept. of Para-Clinical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago. Phone: 868-645-2640, ext. 2332, or 868-736-0440. Fax: 868-663-3797. E-mail: Patrick.Akpaka{at}sta.uwi.edu

{triangledown} Published ahead of print on 3 June 2009.

Journal of Clinical Microbiology, August 2009, p. 2670-2671, Vol. 47, No. 8
0095-1137/09/$08.00+0     doi:10.1128/JCM.00362-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Papp-Wallace, K. M., Bethel, C. R., Distler, A. M., Kasuboski, C., Taracila, M., Bonomo, R. A. (2010). Inhibitor Resistance in the KPC-2 {beta}-Lactamase, a Preeminent Property of This Class A {beta}-Lactamase. Antimicrob. Agents Chemother. 54: 890-897 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»